UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000016029
Receipt number R000018636
Scientific Title Phase I study of afatinib + bevacizumab for advanced NSCLC with EGFR mutation
Date of disclosure of the study information 2014/12/22
Last modified on 2018/12/25 18:41:16

No. Disposal Last modified on Item of update
1 Insert 2014/12/22 16:04:47
2 Update 2015/06/22 10:37:43 Recruitment status
3 Update 2017/06/25 00:40:15 Name of primary person or sponsor
Institute
Organization
Organization
4 Update 2018/12/25 18:41:16 Recruitment status